On 29 June 2012, Commercialisation Australia (CA) announced another $9 million in funding to support 24 new participants and extend additional funds to two existing participants on the program.

Projects that received funding included the first pharmaceutical treatment for cataracts and a light therapy device to assist in the treatment of misaligned circadian rhythms and shift worker sleep disorders. Details of the latest funding offers are available.

The Media Release is available to download here.